APPENDIX II

UNAUDITED PRO FORMA FINANCIAL INFORMATION

B. ASSURANCE REPORT FROM THE REPORTING ACCOUNTANTS ON

UNAUDITED PRO FORMA FINANCIAL INFORMATION

The following is the text of a report received from our reporting accountants, Deloitte
Touche Tohmatsu, Certified Public Accountants, Hong Kong, prepared for the purposes of
incorporation in this prospectus, in respect of the Group’s unaudited pro forma financial
information of our Group.

INDEPENDENT REPORTING ACCOUNTANT’S ASSURANCE REPORT ON THE
COMPILATION OF UNAUDITED PRO FORMA FINANCIAL INFORMATION

To the Directors of Innovent Biologics, Inc.

information of

Inc.

Innovent Biologics,

We have completed our assurance engagement to report on the compilation of unaudited
(the “Company”) and its
pro forma financial
subsidiaries (hereinafter collectively referred to as the “Group”) by the directors of the
Company (the “Directors”) for illustrative purposes only. The unaudited pro forma financial
information consists of the unaudited pro forma statement of adjusted net tangible assets as at
30 June 2018 and related notes as set out on pages II-1 to II-2 of Appendix II to the prospectus
issued by the Company dated 18 October 2018 (the “Prospectus”). The applicable criteria on
the basis of which the Directors have compiled the unaudited pro forma financial information
are described on pages II-1 to II-2 of Appendix II to the Prospectus.

The unaudited pro forma financial information has been compiled by the Directors to
illustrate the impact of the proposed Global Offering (as defined in the Prospectus) on the
Group’s financial position as at 30 June 2018 as if the proposed Global Offering had taken
place at 30 June 2018. As part of this process, information about the Group’s financial position
has been extracted by the Directors from the Group’s historical financial information for each
of the two years ended 31 December 2017 and the six months ended 30 June 2018, on which
an accountants’ report set out in Appendix I to the Prospectus has been published.

Directors’ Responsibilities for the Unaudited Pro Forma Financial Information

The Directors are responsible for compiling the unaudited pro forma financial
information in accordance with paragraph 4.29 of the Rules Governing the Listing of Securities
on The Stock Exchange of Hong Kong Limited (the “Listing Rules”) and with reference to
Accounting Guideline 7 “Preparation of Pro Forma Financial Information for Inclusion in
Investment Circulars” (“AG 7”) issued by the Hong Kong Institute of Certified Public
Accountants (the “HKICPA”).

Our Independence and Quality Control

We have complied with the independence and other ethical requirements of the “Code of
Ethics for Professional Accountants” issued by the HKICPA, which is founded on fundamental
principles of integrity, objectivity, professional competence and due care, confidentiality and
professional behavior.

– II-3 –

